Granulomatous mycosis fungoides, a rare subtype of cutaneous T-cell lymphoma  by Kogut, Marta et al.
CASE REPORTGranulomatous mycosis fungoides, a rare subtype
of cutaneous T-cell lymphoma
Marta Kogut, MD,a Eva Hadaschik, MD,a Stephan Grabbe, MD,b Mindaugas Andrulis, MD,c
Alexander Enk, MD,a and Wolfgang Hartschuh, MDa
Heidelberg and Mainz, GermanyFrom
Ho
ica
Ho
Fund
Confl
Corre
m
44
un
298Key words: Granulomatous dermatitis; granulomatous mycosis fungoides; T-cell receptor gamma gene.Abbreviations used:
GMF: granulomatous mycosis fungoides
INF-a: interferon alfa
MF: mycosis fungoides
TCR: T-cell receptorG
ranulomatous mycosis fungoides (GMF) is
an unusual histologic subtype of cutaneous
T-cell lymphoma.1 The diagnosis of GMF is
usually established after observation of a granulo-
matous inflammatory reaction associated with a
malignant lymphoid infiltrate. Epidermotropism, a
clue to diagnosis in classical mycosis fungoides (MF)
may be absent in about 47% of cases of GMF.2 In
some instances, the granulomatous component may
be intense and obscures the lymphomatous compo-
nent of the infiltrate.1 There are no distinctive clinical
patterns associated with GMF.1,3CASE REPORT
In 1998 a 28 year-old male patient presented with
desquamating erythema on his left auricle (Fig 1, A).
On exam he also had erythematous scaly plaques on
his forearms and trunk associated with surrounding
alopecia (Fig 2, A).
Thirteen years later the now 44-year-old patient
presented with painful ulcers on his left ear, which
recently had started to expand. The ear and
preauricular region appeared erythematous with
profound purulent fistulas and tender ulcerations.
The clinical findings were suggestive of an ulcer-
ated basal cell carcinoma or lupus vulgaris (Fig 1,
B). Previous use of antieczematous, antipsoriatic,
and antifungal therapies with topical steroids,
calcineurin inhibitors, antibiotics, and antiseptics
and systemic and topical antifungals had not made
any improvement. In one previous biopsy from thethe Department of Dermatology, Heidelberg University
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however, polymerase chain reaction results were
negative. The etiologic relevance was considered
questionable, and the appropriate systemic antibi-
otic therapy did not show any effects.
The histopathologic evaluation of biopsy speci-
mens from the ear and forearm found a lympho-
histiocytic, lichenoid inflammatory infiltrate with
epitheloid giant cell granulomas (Fig 3, A and B).
On the basis of the clinical findings of a chronic
ulceration andhistologic evidenceof granulomas,we
favored a disease induced by bacteria or intracellular
parasites. However, the cultures were negative for
mycobacteria and leishmania. Several dermatopa-
thologists were consulted, and a germ-poor myco-
bacteriosis, pinta, and smoldering lymphoma were
considered. However, the analysis of the T-cell
receptor (TCR) gamma gene found a monoclonal
amplification product on a polyclonal background.
A swabof apreauricular fistula grewPseudomonas
aeruginosa and Staphylococcus aureus, which was
positive for Panton-Valentine leukocidin . However,
the appropriate systemic antibiotic therapy did not
yield a therapeutic effect.JAAD Case Reports 2015;1:298-302.
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Fig 1. Clinical presentation of the ear from 1998 until 2013. A, Erythema and desquamation of
the left auricle (1998). B, Development of plaque formation and ulceration (2012). C,
Erythematous, infiltrated plaque and purulent ulcerations, especially in the area of the tragus
and helix leading to mutilation of the helix (March 2013). D, After soft x-ray therapy. Almost
complete healing, leaving a scar plate and subtotal destruction of the helix (December 2013).
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consult with another dermatologic department,which
favored the diagnosis of lupus vulgaris. Without
microbiological evidence, systemicquadruple therapywith rifampicin, isoniazid, ethambutol, and pyrazina-
mide was prescribed without benefit.
In December 2012, the case was discussed with
another dermatopathologist. In one edge of the
Fig 2. Clinical presentation of the right forearm since 2007. A, Erythematous, alopecic scaly
lesion (October 2011). B, Erythematous, scaly, psoriasiform lesions diffusely arranged on the
forearm; alopecia within the lesions (February 2013). C, After cessation of therapy. Only
discrete livid papules; alopecia within the lesion (August 2013).
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which led to the diagnosis of MF with an unusual
granulomatous pattern.
New biopsy samples obtained in January 2013
from the forearm and ear now showed substantial
exocytosis of lymphocytes. The subepithelial infil-
trate was dominated by atypical lymphocytes with
hyperchromatic nuclei. The TCR gene of both bi-
opsies now showed a monoclonal rearrangement
confirming the diagnosis of MF. A retrospective re-
evaluation of our tissue obtained in 2011 (new
recuts: Pautrier microabscess, Fig 3, C and epider-
motropism of CD4-positive lymphocytes by only
scattered CD8-positive T cells, Fig 3, D-F ) confirmed
the diagnosis of MF with severe granulomatous
component.
For therapy, the patient received low-dose inter-
feron alfa (INF-a) with 3 million international units
subcutaneously 3 times a week and additional
photochemotherapy starting in January 2013. The
therapy with INF-a led to an improvement of the
lesions; however, hematotoxicity (lymphocytes
\1500 g/L) led to discontinuation of INF-a inNovember 2013. The consecutive therapy with
bexarotene had to be stopped as well after 8 weeks
because of leukopenia. Percutaneous fractional ra-
diation treatment of the left face with a cumulative
dose of 30 Gy was applied and resulted in complete
remission of the ear tumor (Fig 1, D). Staging has not
found any signs of systemic involvement to date.
DISCUSSION
We report a case of GMF, a rare subtype of MF.
The histologic diagnosis is usually difficult because
of a predominantly granulomatous infiltrate with
only little epidermotropism, which led us to favor
an infectious disease. Clinically, the lesions did not
present as typical MF with eczematous scaly digi-
tated maculae/plaques on the trunk but rather
inconspicuous erythema on the ear in the begin-
ning and alopecia on the forearms. In addition to
this unusual clinical presentation, the diagnosis of
MF was also hampered by the peculiar clinical
course with isolated progress of the lesion on
the ear while the lesions on the arm remained in
an eczematous stage. Not until the ear lesion
Fig 3. Histologic examination of the forearm biopsy. A and B, Lymphohistiocytic inflammatory
infiltrate with formation of epitheloid giant cell granuloma. C-F, Lichenoid lymphohistiocytic
inflammatory infiltrate, exocytosis of lymphocytes. (A-F, Hematoxylin-eosin stain; original
magnifications: A,325; B-F,3100. Immunohistochemistry: D, anti-CD3 staining in red; E, anti-
CD4 staining in red; F, anti-CD8 staining in red.)
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over an infectious disease such as atypical
mycobacteriosis.
Granulomatous infiltrates are an unusual phe-
nomenon in cutaneous lesions of MF.1 The incidence
is estimated in the literature to about 6.3% of cases.4
The degree of the associated histiocytic response
may be variable. It has been postulated that by the
diagnosis of granulomatous cutaneous lymphoma,
the granulomatous component represents at least
25% of the infiltrate.2 The granuloma formation can
be very extensive, and the findings are, as presented
here, often initially misdiagnosed as granulomatous
dermatitis.2
The granulomatous changes may precede,
develop simultaneously, or develop after the signs
of cutaneous lymphoma. The cutaneous granulomas
have a mostly epitheloid appearance.1 The exact
pathogenetic mechanism of granuloma formation in
cutaneous lymphomas is unknown.1
There is no distinctive clinical pattern associ-
ated with the granulomatous variant of MF.1,3 Incontrast, granulomatous slack skin, a distinct
subtype of MF, is characterized by a typical
clinical picture with bulky skin folds.2 The interval
from the onset of symptoms to diagnosis of GMF
is estimated in the literature to about 8.4 years.4
The correct diagnosis is based on histopathologic
features, immunohistochemistry, and TCR rear-
rangement.4,5 According to recent studies, extrac-
utaneous manifestations are more frequent in
GMF and occur earlier than in classical MF. Five-
year survival rate of GMF is 66% worse than that
in classical MF.1
The therapy guidelines for GMF are similar to
those of the classical MF.6 As in our patient,
treatment with photochemotherapy, if necessary,
in combination with INF-a, bexarotene, or radia-
tion treatment can be applied. GMF is a rare form
of MF, which is, as in this case, a challenge to
diagnose.
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